Shanghai Pharmaceuticals Holding Co Ltd Capital Reinvestment Ratio
Shanghai Pharmaceuticals Holding Co Ltd capital reinvestment ratio. Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥1.56 Billion) in capital expenditures (CN¥487.63 Million). Check how aggressively does Shanghai Pharmaceuticals Holding Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shanghai Pharmaceuticals Holding Co Ltd (1999–2025)
Capital reinvestment ratio of Shanghai Pharmaceuticals Holding Co Ltd from 1999 to 2025. This chart tracks Shanghai Pharmaceuticals Holding Co Ltd's Capital Reinvestment Ratio across 27 annual periods. Also explore Shanghai Pharmaceuticals Holding Co Ltd (601607) net asset momentum to track the company's year-over-year net asset growth rate.
Shanghai Pharmaceuticals Holding Co Ltd Capital Reinvestment Ratio by Year (1999–2025)
Shanghai Pharmaceuticals Holding Co Ltd capital reinvestment ratio by year from 1999 to 2025. For the full cash flow conversion analysis, see Shanghai Pharmaceuticals Holding Co Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | CN¥6.15 Billion | CN¥2.33 Billion | ▼ -8.3% |
| 2024 | 0.41x | CN¥5.83 Billion | CN¥2.40 Billion | ▼ -27.4% |
| 2023 | 0.57x | CN¥5.23 Billion | CN¥2.97 Billion | ▲ +0.3% |
| 2022 | 0.57x | CN¥4.74 Billion | CN¥2.68 Billion | ▼ -30.4% |
| 2021 | 0.81x | CN¥5.06 Billion | CN¥4.12 Billion | ▲ +85.1% |
| 2020 | 0.44x | CN¥6.84 Billion | CN¥3.01 Billion | ▼ -3.8% |
| 2019 | 0.46x | CN¥6.02 Billion | CN¥2.75 Billion | ▼ -26.2% |
| 2018 | 0.62x | CN¥3.14 Billion | CN¥1.94 Billion | ▼ -18.2% |
| 2017 | 0.76x | CN¥2.65 Billion | CN¥2.01 Billion | ▼ -30.4% |
| 2016 | 1.09x | CN¥1.95 Billion | CN¥2.12 Billion | ▼ -14.6% |
| 2015 | 1.28x | CN¥1.35 Billion | CN¥1.72 Billion | ▲ +31.9% |
| 2014 | 0.97x | CN¥1.34 Billion | CN¥1.29 Billion | ▲ +4.0% |
| 2013 | 0.93x | CN¥973.45 Million | CN¥905.06 Million | ▲ +50.9% |
| 2012 | 0.62x | CN¥1.15 Billion | CN¥708.91 Million | ▲ +164.0% |
| 2011 | 0.23x | CN¥1.77 Billion | CN¥413.54 Million | ▼ -28.5% |
| 2010 | 0.33x | CN¥1.69 Billion | CN¥550.30 Million | ▲ +171.1% |
| 2009 | 0.12x | CN¥664.13 Million | CN¥79.97 Million | ▼ -62.0% |
| 2008 | 0.32x | CN¥285.68 Million | CN¥90.50 Million | ▼ -19.4% |
| 2007 | 0.39x | CN¥488.94 Million | CN¥192.29 Million | ▲ +51.3% |
| 2006 | 0.26x | CN¥583.11 Million | CN¥151.60 Million | ▼ -90.4% |
| 2005 | 2.71x | CN¥73.00 Million | CN¥198.09 Million | ▼ -34.2% |
| 2004 | 4.13x | CN¥61.66 Million | CN¥254.38 Million | ▼ -98.8% |
| 2003 | 350.18x | CN¥484.27K | CN¥169.58 Million | ▲ +12537.3% |
| 2002 | 2.77x | CN¥100.84 Million | CN¥279.44 Million | ▲ +25.9% |
| 2001 | 2.20x | CN¥65.73 Million | CN¥144.71 Million | ▲ +128.2% |
| 2000 | 0.96x | CN¥146.22 Million | CN¥141.09 Million | ▲ +202.8% |
| 1999 | 0.32x | CN¥164.67 Million | CN¥52.48 Million | — |